Tilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth Opportunities
Author of the article:
Article content
NEUMÜNSTER, Germany, July 29, 2024 (GLOBE NEWSWIRE) Tilray Brands, Inc. (Tilray) (Nasdaq: TLRY; TSX: TLRY), a global leader in medical cannabis research, cult…